[ad_1]
Original title: Overweight! The new corona vaccine has exploded again and the effectiveness of the prevention of serious diseases has reached 100%. The 400 billion giants soared 70% in 4 days, the EU approved the purchase of 2 billion agents, and China became a global brokerage firm.
For the world that has been tortured by the new crown for a whole year, it may now be in darkness before dawn!
On November 30, Moderna announced that its new corona vaccine candidate mRNA-1273 based on mRNA technology has completed the main efficacy data analysis in the phase 3 clinical trial. The 30 severe cases of COVID-19 appeared in the control group, which means that this vaccine is 100% effective in preventing severe cases of COVID-19. The overall effective rate is as high as 94.1%. Without a doubt, this is a great help to the world.
Fueled by this news, Moderna’s share price, which has a market value of US $ 60 billion (nearly RMB 400 billion), has continued to rise recently, with an increase of more than 70% in the last four trading days. Above USD.
According to the latest news, the president of the European Commission stated that the European Commission has approved the purchase of more than 2 billion doses of new candidate corona vaccines and that vaccination work can begin before the end of December. At the same time, the OECD reviewed global economic expectations and saw China as an important driving force. Fueled by this news, global stock markets rose across the board.
A vaccine is available that is 100% effective in preventing severe cases of new crowns.
On November 30 local time, Moderna announced on its official website that its new corona vaccine candidate mRNA-1273 based on mRNA technology has completed the main analysis of efficacy data in the phase 3 clinical trial. Main efficacy analysis based on 196 symptomatic COVID-19 cases shows that the vaccine has an effective rate of 94.1% in protecting symptomatic COVID-19. All 30 severe cases of COVID-19 appeared in the control group.
SinceWuXi AppTecThe content editing team believes this means that this vaccine is 100% effective in preventing severe cases of COVID-19.
Moderna is currently conducting an ongoing review of security data and no serious new security issues have been discovered. According to previous analyzes, the most common adverse reactions include injection site pain, fatigue, myalgia, arthralgia, headache, and injection site redness / erythema. After the second administration, the frequency and severity of spontaneous adverse reactions increased in the mRNA-1273 group. The company will submit the data from the third phase of the COVE study to a peer-reviewed publication.
The company also announced that the FDA’s Vaccines and Related Biologicals Advisory Committee (VRBPAC) will hold a meeting on December 17 to review the safety and efficacy data package for mRNA-1273. By the end of 2020, the company expects to produce approximately 20 million doses of mRNA-1273 and 500 million to 1 billion doses in 2021.
Stéphane Bancel, CEO of Moderna, said: “This positive preliminary analysis confirms the ability of our vaccine to prevent COVID-19 with an effectiveness of 94.1%. Thank you for participating in the phase 1, phase 2 and phase 3 studies. “. Thank you for the tireless efforts of the Moderna team and its partners. We will submit an emergency use authorization request to the FDA today and continue to advance the ongoing review that has been initiated by many regulatory agencies around the world. “
The United States and Europe are pinning their hopes on vaccines
Worldometers real-time global statistics show that at 2:57 p.m. on December 1, Hong Kong time, the cumulative number of confirmed cases of new coronary pneumonia worldwide exceeded 63.6 million, reaching 63,606,238, and the accumulated number of deaths exceeded 1.474 million, reaching 1,474,184. The accumulated number of confirmed cases of new coronary pneumonia in the United States is the highest in the world, exceeding 13.91 million cases, reaching 13920038; the cumulative number of deaths exceeds 274,000, reaching 274,332.
In November, top health officials implored Americans to follow their recommendations and help contain the pandemic. The pandemic killed more than 36,000 people in November, bringing Sunday’s hospitalization to a record nearly 93,000 people.
According to Reuters statistics, more than 4.2 million new COVID-19 infections and 36,000 COVID-19-related deaths were reported in the United States in November. The hospitalization rate is high and the death toll is the highest in six months. According to Reuters analysis of state and county public health reports, there are currently nearly 93,000 Americans hospitalized for COVID-19, an increase of 11% in a single week, which is double the number reported a month ago.
According to CNBC, former director of the US Food and Drug Administration (FDA) Scott Gottlieb stated about the Squawk Box program: “By the end of this year, we may have 30% of the American population . Being infected. “There are approximately 330 million people in the United States. He added,” In states like North Dakota and South Dakota, the infection rate is around 30% to 35%, with the highest being fifty%”.
Without the federal government to stop the spread of the virus, states are imposing new restrictions on business and social life. The California governor said he could renew the stay-at-home ban in the coming days. He warned that unless public health policies and social behavior change, the ICU’s occupancy rate is expected to exceed the state’s carrying capacity by mid-December.
Trump’s attitude toward the new crown has always been hope for a vaccine. US White House press secretary McNerney said the US Food and Drug Administration (FDA) is working hard to handle the approval of the new corona vaccine. The United States government is pressuring agencies to obtain vaccines quickly and safely.
“One hundred percent of Americans who want a vaccine will be vaccinated by (June).” Paul Ostrowski, director of supply, production and distribution for the vaccine program, told MSNBC TV on Monday.
British Prime Minister Johnson stated that the regional alert level will be reviewed every 14 days. The anti-epidemic level should be voted to extend it after the end of February 2. The current level of epidemic prevention in the UK is expected to be maintained until spring.
The president of the European Commission stated that the European Commission has approved the acquisition of more than 2 billion doses of new candidate corona vaccines, and that vaccination work can begin before the end of December.
Global stock markets are on fire
Against the backdrop of the widespread surge in Asia-Pacific stock exchanges during the trading session on December 1, the European and US markets also soared completely. Among them, the Dow index futures of US stocks rose more than 300 points.
Sweden’s central bank governor Inves said the economy is expected to stagnate in the coming quarters and to contract slightly. If necessary, the balance can be expanded. In this case, only the rescue plan can stimulate the market. And just before the market, there was news that the United States House of Representatives Problem Resolution Team will announce the bailout plan supported by both houses, and the United States House of Representatives Problem Resolution Team. and the Senate Team will speak at 10 am local time.
The Organization for Economic Cooperation and Development (OECD) predicts that the world economy will move forward in the next two years. By the end of 2021, real gross domestic product (GDP) growth is expected to reach pre-pandemic levels.
The OECD stated in its latest economic outlook that the world economy is expected to contract 4.2% this year. This reflects an upward revision of the September estimate, which shows a 4.5% drop in real GDP. Looking ahead, the organization stated that the global economy will grow by an average of 4% in the next two years. It expects real GDP growth to reach 4.2% in 2021, which is lower than the 5% forecast in September and 3.7% in 2022.
But the organization warned that there is still “considerable” uncertainty. The Organization for Economic Cooperation and Development (OECD) monitors the economic policies of its 37 member countries and provides them with recommendations, and is cautiously optimistic about the growth momentum of the global economy by 2022.
The report says that by 2021, China is expected to account for more than a third of global economic growth, while Europe and North America’s contribution “will continue to be less than their share of the world economy.”
According to the OECD, China will recover earlier than its peers and will achieve economic growth of 1.8% this year. It is the only major economy expected to achieve economic growth in 2020. And real GDP growth in the world’s second-largest economy is expected to reach 8% next year and 4.9% by 2022. In contrast , the United States is expected to register an economic contraction of 3.7% in 2020, followed by growth of 3.2% and 3.5% in 2021 and 2022, respectively.
Massive information, accurate interpretation, all in the Sina Finance APP
Editor in Charge: Liang Bin SF055
